Picking up the pieces after my vasculitis diagnosis

Picking up the pieces after my vasculitis diagnosis

Janice Barnett poses with a textile piece in the making. (Photos courtesy of Janice Barnett) This is Janice Barnett’s story: My diagnosis of eosinophilic granulomatosis with polyangiitis, formerly known as Churg-Strauss syndrome, in December 2021 plunged me into a state of utter disbelief. I was fit and…

Vasculitis Awareness Month aims to put focus on community voices

May will be an activity-filled month for people living with vasculitis — and for doctors, researchers, and advocates in the field — as the world recognizes Vasculitis Awareness Month (VAM), and International Vasculitis Day on May 15. Vasculitis is a group of rare autoimmune diseases characterized by inflammation and damage…

Tavneos linked to remission in ANCA-associated vasculitis

Tavneos (avacopan) safely and effectively promotes clinical remission in people with newly diagnosed or relapsing ANCA-associated vasculitis (AAV), according to a multicenter, real-world study in the U.S. The remission rates after a year of treatment were higher than those in the Phase 3 ADVOCATE trial (NCT02994927), whose…

Worse sinonasal symptoms linked to higher risk of GPA relapse

Sinonasal symptoms, as assessed with 22-item Sinonasal Outcome Test (SNOT-22), a patient-reported questionnaire, are more severe when ANCA-associated vasculitis (AAV) is active than during remission, a study shows. Sinonasal symptoms are those that affect the nose and the sinuses, that is, the air-filled cavities around the eyes and nose.

DNA-targeting antibodies may be therapeutic options for AAV

Patrys’ PAT-DX1 and PAT-DX3, two DNA-targeting antibodies known as deoxymabs, can suppress production of the antimicrobial webs implicated in ANCA-associated vasculitis (AAV) without weakening other immune responses, according to preclinical work. These webs, called neutrophil extracellular traps (NETs), are made up of a scaffold of DNA and enzymes…